USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Products
Beacon Pharmaceuticals PLC is dedicated to developing high-quality, targeted medications to improve patient outcomes and address complex illnesses. Our mission is to promote global health by providing cost-effective healthcare solutions, and utilizing innovative & advanced manufacturing processes. We offer a wide range of products, including 200 general, and 70 oncology medications across Various therapeutic tic classes.
Browse products list
H
I
W
Products by therapeutic class
Alecinix
Tagrix
Pembroxim
Palbonix
Nilonix
Nivolunix
Ibrutix
Apalunix
Axinix
Briganix
Cabozanix
Crizonix
Enzalunix
Hernix
Lapanix
Niraparix
Nindanix
Olaparix
Pazonix
Ponatinix
Regonix
Ribotix
Sofosvel
Sunitix
Elbonix
Lenvanix
Carboplat
Renesis
Tofacinix
Afanix
Baricinix
Obetix
Resva
Tafecta
Tirzix
Wedica
Adali
Tucatin